Letters Section Editor: Robert M. Golub, MD, Senior Editor.
To the Editor: In their Commentary, Dr Kohane and colleagues1 present the sound general principle that the current wave of enthusiasm for genomic medicine must be tempered by an awareness of the inherent limitations of the field. The potential for false-positives to cloud clinical decision making is certainly present. However, there is an important converse to this idea.
Kruer M. The Incidentalome. JAMA. 2006;296(23):2800-2802. doi:10.1001/jama.296.23.2801-a